Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 575 of 994 entries
View as:

Infusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT04511702 Org: User:
Start: 10/02/20 End: 03/25/24 Due: 03/25/25

A Randomized, Double-Blind Study to Compare the Efficacy of Treatment With Denosumab Versus Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density.

Phase: N/A Priority: Normal
NCT ID: NCT00330460 Org: User:
Start: 05/31/06 End: 01/31/08 Due: 01/31/09

Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00102921 Org: User:
Start: 08/31/04 End: 12/31/05 Due: 12/31/06

Open-Label Study to Evaluate Safety and Efficacy of CCX168 in Subjects With IGA Nephropathy on Stable RAAS Blockade

Phase: N/A Priority: Normal
NCT ID: NCT02384317 Org: User:
Start: 03/27/15 End: 06/01/18 Due: 06/01/19

A Study Comparing the Pharmacokinetics (PK) of ABP 501 40 mg/0.4 mL (ABP 501-HCF) and ABP 501 40 mg/0.8 ml (ABP 501-LCF) in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT05909852 Org: User:
Start: 07/23/21 End: 11/24/21 Due: 11/24/22

Study to Assess if ABP710 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis Compared to Infliximab

Phase: N/A Priority: Normal
NCT ID: NCT02937701 Org: User:
Start: 10/10/16 End: 08/13/18 Due: 08/13/19

Effect of Erenumab-aooe on Disability and Work Productivity in Employed Subjects With Episodic Migraine

Phase: N/A Priority: Normal
NCT ID: NCT03912337 Org: User:
Start: 12/04/19 End: 07/28/21 Due: 07/28/22

Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00115206 Org: User:
Start: 07/31/02 End: 07/31/04 Due: 07/31/05

Rheumatoid Arthritis (DMARD) Intervention and UtilizationStudy

Phase: N/A Priority: Normal
NCT ID: NCT00116714 Org: User:
Start: 10/31/01 End: 10/31/08 Due: 10/31/09

A High-resolution Peripheral Quantitative Computed Tomography Study in Postmenopausal Women Previously Treated With Denosumab

Phase: N/A Priority: Normal
NCT ID: NCT00890981 Org: User:
Start: 07/31/09 End: 08/31/10 Due: 08/31/11

Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis

Phase: N/A Priority: Normal
NCT ID: NCT02732210 Org: User:
Start: 07/06/11 End: 04/14/14 Due: 04/14/15

Evaluating Pegfilgrastim and a Multi-Day Topotecan Regimen in Subjects With Relapsed or Refractory Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00113789 Org: User:
Start: 10/31/03 End: 04/30/05 Due: 04/30/06

A Study to Evaluate the Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AMG 592 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05873907 Org: User:
Start: 10/19/15 End: 07/28/17 Due: 07/28/18

Denosumab Adherence Preference Satisfaction Study

Phase: N/A Priority: Normal
NCT ID: NCT00518531 Org: User:
Start: 09/01/07 End: 06/01/10 Due: 06/01/11

Study of Denosumab in Subjects With Giant Cell Tumor of Bone

Phase: N/A Priority: Normal
NCT ID: NCT00680992 Org: User:
Start: 09/09/08 End: 05/17/18 Due: 05/17/19

A Study Evaluating AMG 193 in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion

Phase: N/A Priority: Normal
NCT ID: NCT06360354 Org: User:
Start: 05/29/24 End: 02/25/29 Due: 02/25/30

Study to Evaluate the Effect of AMG 510 on the Pharmacokinetics (PK) of Digoxin in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05598281 Org: User:
Start: 11/05/19 End: 11/19/19 Due: 11/19/20

Single and Multiple Ascending Dose Study of AMG 513 in Participants With Obesity

Phase: N/A Priority: Normal
NCT ID: NCT06585462 Org: User:
Start: 09/09/24 End: 07/25/26 Due: 07/25/27

Once-weekly Versus Twice-weekly Carfilzomib in Combination With Dexamethasone in Adults With Relapsed and Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT02412878 Org: User:
Start: 09/09/15 End: 01/07/19 Due: 01/07/20

An Open-Label Phase I/II Study of Recombinant Granulocyte Colony Stimulating Factor (r-metHuG-CSF) and Recombinant Erythropoietin (rHuEPO) Given Subcutaneously Along With Zidovudine (AZT) to Patients With the Acquired Immune Deficiency Syndrome (AIDS) or Severe AIDS-Related Complex (ARC)

Phase: N/A Priority: Normal
NCT ID: NCT00002255 Org: User:
Start: - End: - Due: -

Evolocumab Pregnancy Exposure Registry

Phase: N/A Priority: Normal
NCT ID: NCT02957604 Org: User:
Start: 12/22/16 End: 09/02/20 Due: 09/02/21

An Open-label Study to Evaluate the Effect of Treatment With Romosozumab or Teriparatide in Postmenopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT01796301 Org: User:
Start: 01/31/13 End: 05/14/15 Due: 05/14/16

Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT02087943 Org: User:
Start: 06/30/14 End: 02/29/16 Due: 02/28/17

Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01690299 Org: User:
Start: 10/01/12 End: 04/04/16 Due: 04/04/17

Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00556374 Org: User:
Start: 12/18/06 End: 07/26/22 Due: 07/26/23